TRISPECIFIC ANTIBODIES
Provided herein are trispecific antibodies that include a) a first monomer, b) a second monomer, and c) a light chain. The first monomer includes a first variant Fc domain and a variable heavy domain, the second monomer includes a second variant Fc domain and a first scFv domain and the light chain includes a variable light domain. The variable heavy domain and the variable light domain form an antigen binding domain. The trispecific antibody further includes a second scFv domain on either the first or second monomers.
1 . A trispecific antibody comprising:
a) a first monomer comprising a first heavy chain comprising a first variant Fc domain and a first variable heavy domain;
b) a second monomer comprising:
i) a second variant Fc domain;
ii) a first scFv domain; and
c) a light chain comprising a constant light domain and a variable light domain;
wherein the first variable heavy domain and the first variable light domain form an antigen binding domain, and
wherein one of the first and second monomers further comprises a second scFv domain.
2 . The trispecific antibody of claim 1 , wherein the first monomer comprises the second scFv domain.
3 . The trispecific antibody of claim 1 , wherein the second monomer comprises the second scFv domain.
4 . A nucleic acid composition comprising:
a) a first nucleic acid encoding the first monomer of claim 1 ;
b) a second nucleic acid encoding the second monomer of claim 1 ; and
c) a third nucleic acid encoding the third monomer of claim 1 .
5 . An expression vector composition comprising:
a) a first expression vector comprising the first nucleic acid of claim 4 ;
b) a second expression vector comprising the second nucleic acid of claim 4 ; and
c) a third expression vector comprising the third nucleic acid of claim 4 .
6 . A host cell comprising the expression vector composition of claim 5 .
7 . A method of making a trispecific antibody comprising culturing the host cell of claim 6 under conditions wherein the trispecific antibody is expressed and recovering the trispecific antibody.